Cargando…

Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer

Of several subtypes of breast cancer, triple negative breast cancer (TNBC) is a highly aggressive tumor that lacks expression of hormone receptors for estrogen, progesterone and human epidermal growth factor receptor 2 and shows a worst prognosis. The small noncoding RNAs (miRNAs) considered as mast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakur, Seema, Grover, Rajesh K., Gupta, Sanjay, Yadav, Ajay K., Das, Bhudev C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942139/ https://www.ncbi.nlm.nih.gov/pubmed/27404381 http://dx.doi.org/10.1371/journal.pone.0158946

Ejemplares similares

miRNA Signatures in Sera of Patients with Active Pulmonary Tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2013)

The role of NF-κB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection
por: Bano, Nasreen, et al.
Publicado: (2018)

Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer
por: Aftab, Mehreen, et al.
Publicado: (2021)

Triple negative breast cancer: an Indian perspective
por: Akhtar, Murtaza, et al.
Publicado: (2015)

Outcomes of non-metastatic triple negative breast cancers: Real-world data from a large Indian cohort
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer
por: Andrade, Fernando, et al.
Publicado: (2020)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells
por: Jalota, Akansha, et al.
Publicado: (2018)

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature
por: Asztalos, Szilard, et al.
Publicado: (2015)

Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy
por: Rossi, Claudia, et al.
Publicado: (2018)

Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases
por: Benbrook, Doris Mangiaracina, et al.
Publicado: (2022)

Distinct microbiological signatures associated with triple negative breast cancer
por: Banerjee, Sagarika, et al.
Publicado: (2015)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Differential Inhibitory Effects of Curcumin Between HPV+ve and HPV–ve Oral Cancer Stem Cells
por: Bano, Nasreen, et al.
Publicado: (2018)

Identifying miRNA/mRNA negative regulation pairs in colorectal cancer
por: Zhou, Xile, et al.
Publicado: (2015)

Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma
por: Liu, Minglei, et al.
Publicado: (2016)

Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles
por: Wojtowicz, Wojciech, et al.
Publicado: (2020)

Detection of miRNA regulatory effect on triple negative breast cancer transcriptome
por: Martignetti, Loredana, et al.
Publicado: (2015)

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
por: Ferreira, Lívia C., et al.
Publicado: (2020)

Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers
por: Korlimarla, Aruna, et al.
Publicado: (2022)

Comparison of GATA-3, Mammaglobin and GCDFP-15 Expression in Primary, Metastatic and Triple Negative Breast Carcinomas: An Indian Scenario
por: Rao, Meenakshi, et al.
Publicado: (2023)

Role of SMC1 in Overcoming Drug Resistance in Triple Negative Breast Cancer
por: Yadav, Sushma, et al.
Publicado: (2013)

Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of Individuals With Fibromyalgia
por: Fineschi, Serena, et al.
Publicado: (2022)

Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2023)

Perception of Human Papillomavirus Infection, Cervical Cancer and HPV Vaccination in North Indian Population
por: Hussain, Showket, et al.
Publicado: (2014)

Blood Circulating miRNA Pairs as a Robust Signature for Early Detection of Esophageal Cancer
por: Song, Yang, et al.
Publicado: (2021)

Exploration of a Novel Circadian miRNA Pair Signature for Predicting Prognosis of Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2021)

Recent advances in nanotheranostics for triple negative breast cancer treatment
por: Thakur, Vikram, et al.
Publicado: (2019)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma
por: Mustafa, Mohammad Zahid, et al.
Publicado: (2016)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
por: Charan, Manish, et al.
Publicado: (2020)

IgGs-Abzymes from the Sera of Patients with Systemic Lupus Erythematosus Hydrolyzed miRNAs
por: Ermakov, Evgeny A, et al.
Publicado: (2020)

Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients
por: Farace, Cristiano, et al.
Publicado: (2020)

IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs
por: Ermakov, Evgeny A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hock9b62gduv18c0e2g2mnlmnn